Severe Acute Respiratory Syndrome-Coronavirus-2 Antibody Status at the Time of Delivery and the Risk of Preeclampsia
- 13 May 2023
- journal article
- research article
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 41 (S 01) , e2124-e2128
Abstract
Objective Our objective was to evaluate the association between severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) serologic status in immunologically naive patients and the risk of preeclampsia at the time of delivery. Study Design We conducted a retrospective cohort study of pregnant patients admitted to our institution from August 1 to September 30, 2020. We recorded maternal medical and obstetric characteristics and SARS-CoV-2 serologic status. Our primary outcome was the incidence of preeclampsia. Antibody testing was performed, and patients were classified into seropositive groups: immunoglobulin (Ig)G + , IgM + , or both IgG+ and IgM + . Bivariate and multivariable analyses were performed. Results We included 275 patients that were negative for SARS-CoV-2 antibodies, and 165 that were positive. Seropositivity was not associated with higher rates of preeclampsia (p = 0.183) or with preeclampsia with severe features (p = 0.916) even after adjusting for maternal age >35, BMI ≥ 30, nulliparity, and previous history of preeclampsia, and type of serologic status. Previous preeclampsia had the greatest association with the development of preeclampsia (odds ratio [OR] = 13.40; 95% confidence interval [CI]: 4.98–36.09; p < 0.05) and with preeclampsia with severe features (OR = 5.46; 95% CI: 1.65–18.02; p < 0.05). Conclusion We found that in an obstetric population, there was no association between SARS-CoV-2 antibody status and the risk of preeclampsia. Key PointsKeywords
This publication has 23 references indexed in Scilit:
- COVID-19 and preeclampsia with severe features at 34-weeks gestationThe American Journal of Emergency Medicine, 2021
- Benefits and limitations of serological assays in COVID-19 infectionIndian Journal of Tuberculosis, 2020
- Maternal COVID-19 infection, clinical characteristics, pregnancy, and neonatal outcome: A prospective cohort studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2020
- SARS‐CoV2 and pregnancy: An invisible enemy?American Journal of Reproductive Immunology, 2020
- Gestational Hypertension and PreeclampsiaObstetrics & Gynecology, 2020
- Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysisAmerican Journal of Obstetrics & Gynecology MFM, 2020
- Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Pre-eclampsia: pathogenesis, novel diagnostics and therapiesNature Reviews Nephrology, 2019
- Preeclampsia, a Disease of the Maternal EndotheliumCirculation, 2011